Latest on Pharmaceutical Industry


Teva hopes to launch migraine drug as soon as September

Teva Pharmaceutical Industries said on Wednesday it could launch its migraine treatment as soon as mid-September, after an initial delay. The debt-ridden company is counting on the drug - fremanezumab - along with Hun..Read More...

Allergan Exercises Option to Acquire Compound from Aptinyx Discovery Platform Under Ongoing Research Collaboration

Aptinyx Inc., a clinical-stage biopharmaceutical company developing transformative therapies for challenging neurologic disorders, today announced Allergan plc (NYSE: AGN) has exercised its option to acquire drug candida..Read More...



10th Clinical Trials Innovation Programme (East Coast) 2018

Double Tree Suites by Hilton Hotel,


Global Bioprocessing & Bioanalytics Congress

Grandior Hotel Prague,
Czech Republic,
Global Engage

Press Releases

mAbxience and Amneal Enter Into an Agreement for Bevacizumab Biosimilar in the United States

mAbxience a company specialized in the research development manufacturing and global commercialization of monoclonal antibody biosimilars part of the Insud Pharma Group and Amneal Pharmaceuticals Inc NYSE AMRX an integra.. Read More...

Trianni, Inc. and Antibody Solutions Announce Licensing Agreement

Trianni Inc and Antibody Solutions jointly announced that Antibody Solutions has entered into a license agreement with TRIANNI for use of The Trianni Mouse a bestinclass fully humanized transgenic mouse platform to suppo.. Read More...

Suppliers of the Month

Product Launch



Latest Reports


Latest Projects


Expert Talk

Aurena Laboratories AB

Aurena Laboratories AB Aurena business model is to offer support brand owners to launch innovative and competitive products with shortest possible time to market We produce the product to companies around the world. Read More...
Magnus Hedman
Director Business Development Marketing